<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2093</article-id><article-id pub-id-type="doi">10.32687/1561-5936-2026-30-3-262-266</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Analysis of the physical accessibility of drugs for the treatment of osteoporosis in pharmacies in the Penza region</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Pronkina</surname><given-names>Anna A.</given-names></name><bio></bio><email>annapronkina2308@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Egorkina</surname><given-names>Anastasiia A.</given-names></name><bio></bio><email>egorkinanastya@icloud.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhirikova</surname><given-names>Valeriia I.</given-names></name><bio></bio><email>zhirikovavaleria@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Penza State University, Penza, Russia</aff><pub-date date-type="epub" iso-8601-date="2026-09-28" publication-format="electronic"><day>28</day><month>09</month><year>2026</year></pub-date><volume>30</volume><issue>3</issue><fpage>262</fpage><lpage>266</lpage><history><pub-date date-type="received" iso-8601-date="2026-09-29"><day>29</day><month>09</month><year>2026</year></pub-date></history><permissions><copyright-statement>Copyright © 2026,</copyright-statement><copyright-year>2026</copyright-year></permissions><abstract>Ensuring the physical availability of medicines, especially for the treatment of socially significant diseases such as osteoporosis, is a key task for the healthcare system and the pharmaceutical market. The absence of necessary medicines in pharmacies can lead to interruptions in treatment, progression of the disease, and an increased risk of disability among the population.</abstract><kwd-group xml:lang="en"><kwd>osteoporosis</kwd><kwd>physical accessibility</kwd><kwd>pharmacy assortment</kwd><kwd>Penza region</kwd><kwd>bisphosphonates</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>остеопороз</kwd><kwd>физическая доступность</kwd><kwd>аптечный ассортимент</kwd><kwd>Пензенская область</kwd><kwd>бисфосфонаты</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Dedov I. I., Melnichenko G. A., Belaia Zh.E. et al. Osteoporosis — from a rare symptom of endocrine diseases to a silent epidemic of the XX–XXI century. Problems of Endocrinology. 2011;57(1):35—45. (In Russ.)</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Golounina O. O., Belaia Zh.E. Bisphosphonates: 50 years in medical practice. Consilium Medicum. 2020;22(4):66—73. (In Russ.)</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Pathological fractures complicating osteoporosis: clinical guidelines of the Russian Federation. ID: 614_3. Russian Association of Endocrinologists, Association of Traumatologists and Orthopeds of Russia, Association of Rheumoorthopedists. Approved by the Scientific and Practical Council of the Ministry of Health of Russia. Moscow; 2025. (In Russ.)</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Alekseeva V. A. Priority areas for improving pharmaceutical care for patients with osteoporosis. Cand. pharm. sci. diss. Moscow; 2024:10—16. (In Russ.)</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Doskina E. V. Osteoporosis — difficulties in treating the disease and ways to overcome them. Russian Medical Journal. 2011;27(3):1685. (In Russ.)</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Rosstat. Healthcare in Russia. 2025: statistical collection. Moscow; 2025. (In Russ.)</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>DSM Group. Study of the pharmacy market of the Penza region. Results of 2024. Moscow; 2025. (In Russ.)</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Alekseeva V. A., Krikova A. V. Analysis of the market for osteoporosis drugs and prospects for its development in the Russian Federation. Remedium. 2023;27(2):123—127. (In Russ.)</mixed-citation></ref></ref-list></back></article>
